Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 3.040
+0.050 (1.67%)
At close: Mar 20, 2026
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 204.67 million as of March 20, 2026. Its market cap has decreased by -44.78% in one year.
Market Cap
204.67M
Enterprise Value
169.76M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.04
Market Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 204.67M, an increase of 306.37%. That is a compound annual growth rate of 16.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 204.67M | 1.01% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipum AB | 304.40M |
| Elicera Therapeutics AB | 262.58M |
| Intervacc AB | 251.86M |
| Mendus AB | 242.63M |
| Sprint Bioscience AB | 210.50M |
| AlzeCure Pharma AB | 197.65M |
| Xintela AB | 187.76M |
| Isofol Medical AB | 185.53M |